Title:
二次的な組織変性のCXCL10処置
Document Type and Number:
Japanese Patent JP2005501036
Kind Code:
A
Abstract:
The invention provides a method of reducing the severity of secondary tissue degeneration associated with CNS injury in a subject by administering to a subject having secondary tissue degeneration associated with CNS injury an effective amount of a neutralizing agent specific for interferon inducible protein of 10 kDa (CXCL10).
Inventors:
Key Earth, Hans S.
Rain, Thomas E.
Rain, Thomas E.
Application Number:
JP2003511851A
Publication Date:
January 13, 2005
Filing Date:
July 12, 2002
Export Citation:
Assignee:
The Regents of The University of California
International Classes:
C12N15/09; A61K9/127; A61K31/7088; A61K39/395; A61K45/00; A61K48/00; A61P9/10; A61P21/00; A61P25/00; A61P25/02; C07K14/52; C07K16/18; (IPC1-7): A61K45/00; A61K9/127; A61K31/7088; A61K39/395; A61K48/00; A61P9/10; A61P21/00; A61P25/00; A61P25/02
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita